Texture Analysis of T1-Weighted Contrast-Enhanced Magnetic Resonance Imaging Potentially Predicts Outcomes of Patients with Non-Wingless-Type/Non-Sonic Hedgehog Medulloblastoma
Overview
Affiliations
Objective: To investigate whether tumor texture features derived from preoperative T1-weighted magnetic resonance imaging (MRI) are associated with overall survival (OS) of patients with non-wingless-type (WNT)/non-sonic hedgehog (SHH) medulloblastoma.
Methods: We retrospectively reviewed 38 patients with non-WNT/non-SHH (encompassing group 3 and group 4) medulloblastoma treated with surgery in our institution from 2013 to 2016. All patients were followed-up for at least 2 years or until death. Primary tumor traditional parameters were evaluated, and texture features were extracted from preoperative T1-weighted MRI, including 4 features from the histogram matrix and 6 textures from the gray-level co-occurrence matrix (GLCM). Texture features were dichotomized into 2 subgroups based on their optimal cutoff values obtained from receiver operating characteristics curve analysis. Two-year OS was compared between the dichotomized subgroups using the Kaplan-Meier analysis and log-rank test. Multivariate Cox regression analysis was performed to determine independent prognostic factors.
Results: The therapy regimen was the only basic characteristic significantly related to 2-year OS (P = 0.015). Two features of the GLCM were shown to be significantly associated with 24-month OS. Multivariate Cox regression analysis revealed that GLCM homogeneity (adjusted hazard ratio, 0.145; P = 0.013) was an independent prognostic predictor for patients.
Conclusions: Texture analysis on T1-weighted contrast-enhanced MRI potentially serves as a prognostic predictor of survival for patients with non-WNT/non-SHH medulloblastoma.
Fotouhi M, Shahbandi A, Mehr F, Shahla M, Nouredini S, Kankam S Neurosurg Rev. 2024; 47(1):827.
PMID: 39467891 DOI: 10.1007/s10143-024-03060-1.
Sun D, Dong J, Mu Y, Li F Contrast Media Mol Imaging. 2022; 2022:2279018.
PMID: 35935311 PMC: 9325563. DOI: 10.1155/2022/2279018.
Risk Factors for Survival in Patients With Medulloblastoma: A Systematic Review and Meta-Analysis.
Liu Y, Xiao B, Li S, Liu J Front Oncol. 2022; 12:827054.
PMID: 35311074 PMC: 8927734. DOI: 10.3389/fonc.2022.827054.